Perbedaan UBC Medical Indonesia Tbk. dan Mandiri Herindo Adiperkasa Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Mandiri Herindo Adiperkasa Tbk. diperdagangkan di Rp141 (kapitalisasi pasar 2,33 T, volume 24 jam 2,7 jt). Perbedaan utamanya: Mandiri Herindo Adiperkasa Tbk. jauh lebih besar — sekitar 4× kapitalisasi pasar UBC Medical Indonesia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (3,48 jt vs 2,7 jt). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | MAHA | |
|---|---|---|
Kapitalisasi Pasar | 576,7 M | 2,33 T |
Volume | 3,48 jt | 2,7 jt |
Lot | 34,82 rb | 27 rb |
Perputaran | 522,79 jt | 378,94 jt |
Harga Rata-rata | 150,13 | 140,36 |
Nilai Transaksi | 522,79 jt | 378,94 jt |
Harga Ekuilibrium Indikatif | 148 | 142 |
Volume Ekuilibrium Indikatif | 350 | 20 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →PT Mandiri Herindo Adiperkasa Tbk. (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Julia Rochana Murat, S.H., No. 18 dated January 25, 1994. The Company started commercial activities in 1994.
Selengkapnya di halaman MAHA →